Skip to content

Clinical trials

Phase 2 Alzheimer Disease trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 2 Country / region: Taiwan Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20121
20153
20171
20182
20193
20201
20221
20231
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status6
Recruiting4
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chang Gung Memorial Hospital8
GlaxoSmithKline2
United Neuroscience Ltd.2
Botanicure Co., Ltd.1
Eli Lilly and Company1
Elixiron Immunotherapeutics Inc.1
Excelsior1
National Taiwan University Hospital1
Sinphar Pharmaceutical Co., Ltd1
Taipei Medical University Shuang Ho Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease19
Cognitive Dysfunction6
Dementia4
Brain Diseases3
Nervous System Diseases3
Central Nervous System Diseases2
Frontotemporal Dementia2
Mental Disorders2
Neurodegenerative Diseases2
Plaque, Amyloid2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.